PROFOUND MEDICAL CORP (PROF:NASDAQ)
$6.625 -0.025 (-0.3759%)
Analysed PROFOUND MEDICAL CORP (PROF:NASDAQ) News Sources
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates
30-04-2026
yahoo.com
Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near Future
03-05-2026
yahoo.com
Profound Medical Reports Strong First Quarter 2026 Financial Results
07-05-2026
yahoo.com
Profound Medical Down 8.5% After Hours as Its Q1 Loss Narrows, Revenue More Than Doubles, Beats Estimates
07-05-2026
yahoo.com
Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates
07-05-2026
yahoo.com
Profound Medical Q1 Earnings Call Highlights
08-05-2026
marketbeat.com
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
14-05-2026
yahoo.com
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
14-05-2026
yahoo.com
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
15-05-2026
yahoo.com
Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?
18-05-2026
yahoo.com
What is the current price of PROFOUND MEDICAL CORP (PROF:NASDAQ)?
The current price of PROFOUND MEDICAL CORP (PROF:NASDAQ) is $6.625.
PROFOUND MEDICAL CORP (PROF:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROFOUND MEDICAL CORP (PROF:NASDAQ) since the previous trading day is $-0.025.
PROFOUND MEDICAL CORP (PROF:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROFOUND MEDICAL CORP (PROF:NASDAQ) since the previous trading day is -0.3759%.
What is the most recent average sentiment score for PROFOUND MEDICAL CORP (PROF:NASDAQ)?
The most recent average sentiment score for PROFOUND MEDICAL CORP (PROF:NASDAQ) is 53 out of 100.
What is the most recent average sentiment for PROFOUND MEDICAL CORP (PROF:NASDAQ)?
The most recent sentiment for PROFOUND MEDICAL CORP (PROF:NASDAQ) is .
SEC-8K** Filing Available For PROFOUND MEDICAL CORP (PROF:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.